Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongyi Xie

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinical, Cosmetic and Investigational Dermatology|January 27, 2022
Identification of Serum Biomarkers and Pathways of Systemic Lupus Erythematosus with Skin Involvement Through GC/MS-Based Metabolomics AnalysisYongyi Xie, Baoyi Liu, Zhouwei Wu
Dermatology (Basel, Switzerland)|December 10, 2020
Identification of Candidate Genes and Pathways in Nonsegmental Vitiligo Using Integrated Bioinformatics MethodsBaoyi Liu, Yongyi Xie, Zhouwei Wu
Oxidative Medicine and Cellular Longevity|March 21, 2022
Four-Octyl Itaconate Attenuates UVB-Induced Melanocytes and Keratinocytes Apoptosis by Nrf2 Activation-Dependent ROS InhibitionYongyi Xie, Zile Chen, Zhouwei Wu
Evidence-Based Complementary and Alternative Medicine : Ecam|December 31, 2020
Astragaloside IV Enhances Melanogenesis via the AhR-Dependent AKT/GSK-3<i>β</i>/<i>β</i>-Catenin Pathway in Normal Human Epidermal MelanocytesBaoyi Liu, Yongyi Xie, Zhouwei Wu
Medcomm|August 27, 2025
Nanocarrier-Based Systems for Targeted Delivery: Current Challenges and Future DirectionsZichen Xu, Yongyi Xie, Wenjie Chen, et al.
The Journal of Dermatological Treatment|August 5, 2020
Change of dermatological practice after the COVID-19 outbreak resolvesChuang Gao, Baoyi Liu, Yongyi Xie, et al.
International Immunopharmacology|April 7, 2024
Deciphering and overcoming Anti-PD-1 resistance in Melanoma: A comprehensive review of Mechanisms, biomarker Developments, and therapeutic strategiesRuoqi Wang, Yanbin Chen, Yongyi Xie, et al.
Pharmaceutics|July 30, 2025
Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer TherapyJiapeng Wang, Renjie Chen, Yongyi Xie, et al.
Journal of Dermatological Science|April 17, 2023
Roflumilast enhances the melanogenesis and attenuates oxidative stress-triggered damage in melanocytesZile Chen, Yiting Li, Yongyi Xie, et al.
Experimental and Therapeutic Medicine|January 18, 2021
Reciprocal regulation of interleukin-17A and interleukin-22 secretion through aryl hydrocarbon receptor activation in CD4<sup>+</sup> T cells of patients with vitiligoBaoyi Liu, Yongyi Xie, Xingyu Mei, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical, Cosmetic and Investigational Dermatology|January 27, 2022
Identification of Serum Biomarkers and Pathways of Systemic Lupus Erythematosus with Skin Involvement Through GC/MS-Based Metabolomics AnalysisYongyi Xie, Baoyi Liu, Zhouwei Wu
Dermatology (Basel, Switzerland)|December 10, 2020
Identification of Candidate Genes and Pathways in Nonsegmental Vitiligo Using Integrated Bioinformatics MethodsBaoyi Liu, Yongyi Xie, Zhouwei Wu
Oxidative Medicine and Cellular Longevity|March 21, 2022
Four-Octyl Itaconate Attenuates UVB-Induced Melanocytes and Keratinocytes Apoptosis by Nrf2 Activation-Dependent ROS InhibitionYongyi Xie, Zile Chen, Zhouwei Wu
Evidence-Based Complementary and Alternative Medicine : Ecam|December 31, 2020
Astragaloside IV Enhances Melanogenesis via the AhR-Dependent AKT/GSK-3<i>β</i>/<i>β</i>-Catenin Pathway in Normal Human Epidermal MelanocytesBaoyi Liu, Yongyi Xie, Zhouwei Wu
Medcomm|August 27, 2025
Nanocarrier-Based Systems for Targeted Delivery: Current Challenges and Future DirectionsZichen Xu, Yongyi Xie, Wenjie Chen, et al.
The Journal of Dermatological Treatment|August 5, 2020
Change of dermatological practice after the COVID-19 outbreak resolvesChuang Gao, Baoyi Liu, Yongyi Xie, et al.
International Immunopharmacology|April 7, 2024
Deciphering and overcoming Anti-PD-1 resistance in Melanoma: A comprehensive review of Mechanisms, biomarker Developments, and therapeutic strategiesRuoqi Wang, Yanbin Chen, Yongyi Xie, et al.
Pharmaceutics|July 30, 2025
Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer TherapyJiapeng Wang, Renjie Chen, Yongyi Xie, et al.
Journal of Dermatological Science|April 17, 2023
Roflumilast enhances the melanogenesis and attenuates oxidative stress-triggered damage in melanocytesZile Chen, Yiting Li, Yongyi Xie, et al.
Experimental and Therapeutic Medicine|January 18, 2021
Reciprocal regulation of interleukin-17A and interleukin-22 secretion through aryl hydrocarbon receptor activation in CD4<sup>+</sup> T cells of patients with vitiligoBaoyi Liu, Yongyi Xie, Xingyu Mei, et al.
Pageof 3